<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>IC
   <sub>50</sub> values botanicals from the leaves of 
   <italic>Acacia sieberiana</italic> towards of drug sensitive and MDR cancer cells lines after 72 h incubation.
  </p>
 </caption>
 <alt-text id="alttext0040">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="3">Cell lines</th>
    <th colspan="4">Samples, IC
     <sub>50</sub> values in μg/mL and degrees of resistance∗ or selectivity index∗∗
     <hr/>
    </th>
   </tr>
   <tr>
    <th>Crude extract
     <hr/>
    </th>
    <th colspan="3">Fractions
     <hr/>
    </th>
   </tr>
   <tr>
    <th>ASL</th>
    <th>ASLa</th>
    <th>ASLb</th>
    <th>ASLc</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>CCRF-CEM</td>
    <td>
     <bold>13.45 ± 2.12</bold>
    </td>
    <td>44.17 ± 3.58</td>
    <td>23.08 ± 1.72</td>
    <td>
     <bold>16.42 ± 1.33</bold>
    </td>
   </tr>
   <tr>
    <td>CEM/ADR5000
     <break/>Degree of resistance∗
    </td>
    <td>
     <bold>14.26 ± 0.88</bold>
     <break/>1.06
    </td>
    <td>&gt;80
     <break/>&gt;1.81
    </td>
    <td>26.55 ± 3.22
     <break/>1.15
    </td>
    <td>20.17 ± 1.17
     <break/>1.23
    </td>
   </tr>
   <tr>
    <td>MDA-MB-231-
     <italic>pcDNA</italic>
    </td>
    <td>27.76 ± 4.09</td>
    <td>33.61 ± 1.83</td>
    <td>31.82 ± 1.72</td>
    <td>29.64 ± 2.55</td>
   </tr>
   <tr>
    <td>MDA-MB-231-
     <italic>BCRP</italic>
     <break/>Degree of resistance
    </td>
    <td>33.20 ± 3.13
     <break/>1.20
    </td>
    <td>38.12 ± 2.40
     <break/>1.13
    </td>
    <td>22.94 ± 3.01
     <break/>0.72
    </td>
    <td>20.27 ± 1.16
     <break/>0.68
    </td>
   </tr>
   <tr>
    <td>HCT116 (
     <italic>p53</italic>
     <sup>
      <italic>+/+</italic>
     </sup>)
    </td>
    <td>
     <bold>18.85 ± 1.10</bold>
    </td>
    <td>28.14 ± 0.96</td>
    <td>34.52 ± 2.37</td>
    <td>
     <bold>16.71 ± 1.84</bold>
    </td>
   </tr>
   <tr>
    <td>HCT116 (
     <italic>p53</italic>
     <sup>
      <italic>−/−</italic>
     </sup>)
     <break/>Degree of resistance
    </td>
    <td>
     <bold>17.23 ± 2.01</bold>
     <break/>0.91
    </td>
    <td>&gt;80
     <break/>&gt;2.84
    </td>
    <td>40.19 ± 3.51
     <break/>1.16
    </td>
    <td>23.87 ± 1.76
     <break/>1.41
    </td>
   </tr>
   <tr>
    <td>U87MG</td>
    <td>
     <bold>19.44 ± 1.89</bold>
    </td>
    <td>44.16 ± 4.78</td>
    <td>32.12 ± 2.46</td>
    <td>28.09 ± 1.81</td>
   </tr>
   <tr>
    <td>U87MG.Δ
     <italic>EGFR</italic>
     <break/>Degree of resistance
    </td>
    <td>
     <bold>16.78 ± 1.72</bold>
     <break/>0.86
    </td>
    <td>27.30 ± 3.28
     <break/>0.62
    </td>
    <td>23.66 ± 1.19
     <break/>0.74
    </td>
    <td>21.11 ± 1.97
     <break/>0.75
    </td>
   </tr>
   <tr>
    <td>HepG2</td>
    <td>21.65 ± 2.09</td>
    <td>&gt;80</td>
    <td>38.95 ± 2.87</td>
    <td>23.19 ± 2.08</td>
   </tr>
   <tr>
    <td>AML12
     <break/>Selectivity index∗∗
    </td>
    <td>67.53 ± 4.76
     <break/>3.12
    </td>
    <td>&gt;80 nd</td>
    <td>&gt;80
     <break/>2.05
    </td>
    <td>67.86 ± 4.91
     <break/>2.93
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>(∗): The degree of resistance was determined as the ratio of IC
    <sub>50</sub> value in the resistant divided by the IC
    <sub>50</sub> in the sensitive cell line; CEM/ADR5000, MDA-MB-231-
    <italic>BCRP,</italic> HCT116 (
    <italic>p53</italic>
    <sup>
     <italic>−/−</italic>
    </sup>) and U87MG.Δ
    <italic>EGFR</italic> were used as the corresponding resistant counterpart for CCRF-CEM, MDA-MB-231-
    <italic>pcDNA</italic>, HCT116 (
    <italic>p53</italic>
    <sup>
     <italic>+/+</italic>
    </sup>), U87MG respectively; (∗∗): The selectivity index was determined as the ratio of IC
    <sub>50</sub> value in the normal AML12 hepacytes divided by the IC
    <sub>50</sub> in HepG2 hepatocarcinoma cells; In bold: Significant cytotoxic effect [
    <xref rid="bib30" ref-type="bibr">30</xref>, 
    <xref rid="bib34" ref-type="bibr">34</xref>, 
    <xref rid="bib35" ref-type="bibr">35</xref>]; nd: not determined; ASL: crude CH2Cl2:MeOH (1:1) extract from the leaves of 
    <italic>Acacia sieberiana</italic>, ASLa: Hexane fractions from ASL; ASLb: ethyl acetate fraction from ASL; ASLc: n-butanol fraction from ASL; nd: not determined; The data for doxorubicin used as positive control in similar experimental conditions are shown in 
    <xref rid="tbl2" ref-type="table">Table 2</xref>.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
